Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall naproxenConcern about Aleve side effects is mounting in light of a public announcement made by the FDA regarding clinical evidence suggesting that Aleve may cause increased cardiovascular risks. On December 20, 2004 the Food and Drug administration publicized information from a clinical study revealing that patients taking naproxen are at a fifty percent greater risk of suffering from heart attack or stroke than patients who are not taking naproxen.
Naproxen is the generic name for a group of non-steroidal anti-inflammatory drugs (NSAIDs) that are used to treat the severe pain associated with arthritis, menstrual cramps, tendonitis, bursitis, gout, and a number of other pain conditions. Naproxen is available in both prescription strength (called naprosyn and anaprox) and non-prescription or over-the-counter strength known as Aleve.
Aleve has been available over-the-counter in the United States since 1976. Common Aleve side effects have been known to include nausea, headache, heartburn, rah or hives, ringing in the ears, shortness of breath, and swollen face, legs, or feet. Serious gastrointestinal Aleve side effects have long been a risk associated with this medication. Gastrointestinal Aleve side effects can be presented in the following symptoms: nausea, constipation, flatulence, and- in more serious cases- black or blood vomit or stools. These latter symptoms may be the Aleve side effects that indicate gastrointestinal bleeding or ulcer that can prove fatal in more severe cases.
Aleve side effects are also greater for patients with certain existing medical conditions. Patients in the third trimester of pregnancy or those who are breast feeding are advised not to take Aleve, because of potential adverse Aleve side effects that can cause injury to a developing fetus or newborn. Patients who have heart complications, kidney or liver problems, diabetes, allergies to similar medications, and blood disorders may also be at greater risk of suffering Aleve side effects, and are therefore cautioned that Aleve may not be an appropriate treatment method.
New naproxen warnings are now suggesting that Aleve side effects may also include cardiovascular complications. The National Institutes of Health initiated a study in 2001 to test naproxen’s effectiveness at preventing Alzheimer’s in elderly patients. This clinical trial (ADAPT) was cut short after researchers discovered that patients in the naproxen group were more likely to suffer from adverse cardiovascular events than the control group. The clinical trial participants who had been taking naproxen were taking a dose equal to that of Aleve.
Regulators, researchers and pharmaceutical manufacturers of naproxen drugs are all currently looking into these preliminary findings to evaluate their statistical significance and the exact extent of possible cardiovascular Aleve side effects. If you or a loved one is currently taking Aleve and experience any adverse Aleve side effects, you may wish to contact your physician. If you are concerned about cardiovascular Aleve side effects, you may also wish to address these concerns with your health care professional.
The FDA says it is working with the National Institutes of Health to review available scientific information on naproxen, sold under the brand name Aleve by Bayer, after the decision to halt a clinical trial studying the effect of naproxen on patients...